Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women

Journal of Bone and Mineral Research

Volumn 24, Issue 6, 2009, Pages 983-991

  Binkley, Neil ^a   Harke, Judith ^a   Krueger, Diane ^a   Engelke, Jean ^a   Vallarta Ast, Nellie ^a   Gemar, Dessa ^a   Checovich, Mary ^a   Chappell, Richard ^b   Suttie, John ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Menatetrenone; Osteoporosis; Phylloquinone; Undercarboxylated osteocalcin; Vitamin K

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CITRATE CALCIUM; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; PLACEBO;

ADULT; ARTICLE; BONE TURNOVER; CARBOXYLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; OSTEOPOROSIS; POSTMENOPAUSE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ABSORPTIOMETRY, PHOTON; ALKALINE PHOSPHATASE; BONE DENSITY; BONE REMODELING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; OSTEOCALCIN; PLACEBOS; POSTMENOPAUSE; VITAMIN K; VITAMIN K 1; VITAMIN K 2;

EID: 66349101037     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.081254     Document Type: Article

References (49)

1. Suttie JW 1990 Warfarin and vitamin K. Clin Cardiol 13:16-18. (Pubitemid 20150174)
2. Price PA 1989 Gla-containing proteins of bone. Connect Tissue Res 21:51-60.
3. Knapen MH, Jie KS, Hamulyak K, Vermeer C 1993 Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int 53:81-85. (Pubitemid 23215380)
4. Binkley NC, Krueger DC, Foley AL, Engelke JA, Suttie JW 2000 Vitamin K supplementation reduces serum under gamma-carboxylated osteocalcin concentration in healthy adults. Am J Clin Nutr 72:1523-1528.
5. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA 1997 Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 65:779-784. (Pubitemid 27111085)
6. Martini LA, Booth SL, Saltzman E, do Rosario Dias E, de Oliveria Latorre M, Wood RJ 2006 Dietary phylloquinone depletion and repletion in postmenopausal women: Effects on bone and mineral metabolism. Osteoporos Int 17:929-935. (Pubitemid 43781508)
7. Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, Dawson-Hughes B, Wilson PW, Cupples LA, Kiel DP 2003 Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 77:512-516. (Pubitemid 36133397)
8. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA 1999 Vitamin K intake and hip fractures in women: A prospective study. Am J Clin Nutr 69:74-79. (Pubitemid 29031254)
9. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wilson PWF, Ordovas J, Schaeffer EJ, Dawson-Hughes B, Kiel DP 2000 Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71:1201-1208. (Pubitemid 30230569)
10. Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769-1774. (Pubitemid 23127383)
11. Price PA 1993 Vitamin K nutrition and postmenopausal osteoporosis. J Clin Invest 91:1268.
12. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ 2006 Vitamin K and the prevention of fractures: Systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256-1261. (Pubitemid 43967576)
13. Rejmmark L, Vestergaard P, Charles P, Hermann AP, Brot C, Eiken P, Mosekilde L 2006 No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int 17:1122-1132.
14. Binkley N, Krueger D, Engelke JA, Suttie JW 2007 Long-term warfarin treatment does not alter skeletal status in male rhesus monkeys. J Bone Miner Res 22:695-700.
15. Braam LAJLM, Knapen MHJ, Geusens P, Brouns F, Hamulyak K, Gerichhausen MJW, Vermeer C 2003 Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73:21-26. (Pubitemid 37022075)
16. 3 plus calcium on the bone health of older women. J Bone Miner Res 22:509-519. (Pubitemid 47457427)
17. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B 2008 Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93:1217-1223.
18. Suttie JW 1995 The importance of menaquinones in human nutrition. Annu Rev Nutr 15:399-417.
19. Davidson RT, Foley AL, Engelke JA, Suttie JW 1998 Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J Nutr 128:220-223. (Pubitemid 28124990)
20. 3 and estrogen-progestin therapy. Maturitas 31:161-164. (Pubitemid 29074386)
21. Iwamoto J, Takeda T, Ichimura S 2001 Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: A comparison of the effect with etidronate. J Orthop Sci 6:487-492. (Pubitemid 34019555)
22. Sato Y, Honda Y, Kuno H, Oizumi K 1998 Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 23:291-296. (Pubitemid 28434674)
23. Shiraki M, Shiraki Y, Aoki C, Miura M 2000 Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15:515-521. (Pubitemid 30134096)
24. Orimo H, Shiraki M, Fujita T, Onomura T, Inoue T, Kushida K 1992 Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis-a double-blind multicenter comparative study with 1 alpha hydroxyvitamin D. J Bone Miner Res 7:S1;S122.
25. Orimo H, Shiraki M, Tomita A, Morii H, Fujita T, Ohata M 1998 Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study. J Bone Miner Metab 16:106-112. (Pubitemid 28313298)
26. Sugiyama T 2007 Possible involvements of vitamin K in bone quality. Arch Intern Med 167:93. (Pubitemid 46072414)
27. Knapen MHJ, Schurgers LJ, Vermeer C 2007 Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18:963-972. (Pubitemid 46889558)
28. Gundberg C, Nieman SD, Abrams S, Rosen H 1998 Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-3266. (Pubitemid 28500970)
29. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW 2002 A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr 76:1055-1060. (Pubitemid 35244677)
30. Yoshikawa T, Turner CH, Peacock M, Slemenda CW, Weaver CM, Teegarden D, Markwardt P, Burr DB 1994 Geometric structure of the femoral neck measured using dual-energy x-ray absorptiometry. J Bone Miner Res 10:1053-1064. (Pubitemid 24191793)
31. Faulkner KG, Wacker WK, Barden HS, Simonelli C, Burke PK, Ragi S, Del Rio L 2006 Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int 17:593-599.
32. Venables WN, Ripley BD 2002 Modern Applied Statistics with S, 4th ed. Springer, New York, NY, USA.
33. Gundberg CM, Nieman SD, Abrams S, Rosen H 1998 Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-3266. (Pubitemid 28500970)
34. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD 1994 Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9:1591-1595. (Pubitemid 24300109)
35. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD 1997 Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS study. J Clin Endocrinol Metab 82:719-724. (Pubitemid 27106576)
36. Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1996 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study. Bone 18:487-488. (Pubitemid 26152313)
37. Ishida Y, Kawai S 2004 Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi osteoporosis prevention study. Am J Med 117: 549-555. (Pubitemid 39304204)
38. Sato Y, Kanoko T, Satoh K, Iwamoto J 2005 Menatetrenone and vitamin D2 with calcium supplements prevent non-vertebral fracture in elderly women with Alzheimer's disease. Bone 36:61-68. (Pubitemid 40128275)
39. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R 2005 Estimates of optimal vitamin D status. Osteoporos Int 16:713-716. (Pubitemid 40933586)
40. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B 2005 Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293:2257-2264. (Pubitemid 40629192)
41. Haffa A, Krueger D, Bruner J, Engelke J, Gundberg C, Akhter M, Binkley N 2000 Diet or warfarin induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res 15:872-878. (Pubitemid 30233410)
42. McLean RR, Booth SL, Kiel DP, Broe KE, Gagnon DR, Tucker KL, Cupples LA, Hannan MT 2006 Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and women. Osteoporos Int 17:600-607.
43. Anonymous 2001 Osteoporosis prevention, diagnosis and therapy NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA 285:785-795.
44. Seeman E, Delmas P 2006 Bone quality-The material and structural basis of bone strength and fragility. N Engl J Med 354:2250-2261. (Pubitemid 43788139)
45. Iwamoto J, Takeda T, Sato Y 2006 Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis. Nutr Rev 64:509-517. (Pubitemid 46057718)
46. Akiyama Y, Hara K, Ohkawa I, Tajima T 1993 Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol 62:145-153. (Pubitemid 23218233)
47. Binkley N, Krueger D, Engelke JA, Crenshaw T, Suttie JW 2002 Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats. Bone 30:897-900. (Pubitemid 34616020)
48. Tamura T, Morgan SL, Takimoto H 2007 Vitamin K and the prevention of fractures. Arch Intern Med 167:94. (Pubitemid 46072415)
49. Anonymous 2005 Eisai announces the intermediate analysis of anti-osteoporosis treatment post-marketing research to investigate the benefits of menatetrenone as part of the ministry of health, labour and welfare's pharmacoepidemiological drug preview program Available online at www.eisai.co.jp/enews/enews200506.html. Accessed September 2, 2008.